Target Product Profiles

Balancing Physician Expectations with Development Reality

Target Product Profiles are the most cost-effective way to measure physicians’ future prescribing behaviors and build profiles of realistic, impactful drugs. With a two-stage survey methodology, analysis uncover what physicians want to treat for a particular disease and then revisit physician to have them determine their prescribing habits. The Target Product Profiles allow you to discover which drug attributes present the greatest threat to your established drugs as well as how to effectively enter a disease market with a new drug.

The reports, available for 35 indications, include two comprehensive profiles for each disease. One explores the minimum improvement that physicians would be willing to accept for a new drug and the other uncovers what physicians would expect from a maximum achievement.

Questions answered include:

• What are physicians looking for in a new drug?
•  If physicians had this new drug, how would they use it? First line? Second line?
• What would be the patient share?
• Which therapies would the new drug replace?
• What is the estimated price per day for the target drug?

Each Target Product Profile includes:

• Assessment of Product Opportunities – explains the number and type of physicians interviewed and what key aspect of the drug in development is examined. It also explains the relative importance of a drug’s attribute to physicians’ prescribing habits.
• Clinical Trial End Points – outlines the key clinical trial end points for the specific disease and ranks them in order of importance according to the prescribing physicians.
• Physician Survey Results – shows the projected patient share, price per day, and sales based on analysis of survey respondents. It explains what portion of patients would receive the drug as first-line, second-line, and third-line therapy, and what current drugs would be replaced by new therapy.

Download our Target Product Profile topic sheet